STAT Plus: ViiV takes steps to widen access to HIV prevention drug, but continues to encounter criticism
Pharma
Pharma news: STAT covers pharmaceutical companies through every phase of the drug development lifecycle, from early trials to blockbuster sales, from startups to mergers and acquisitions, from innovative CEOs to Big Pharma lobbyists.
Latest
STAT Plus: Harris seeks to tie expanded Medicare drug price negotiation to home care, vision, hearing coverage expansion
STAT Plus: U.S. Supreme Court asks solicitor general for views on controversial Oklahoma law for regulating PBMs
STAT Plus: Pharmalittle: We’re reading about compounders suing the FDA, Biogen turning to telehealth, and more
Scholar Rock sees SMA data boosting obesity effort
STAT Plus: Compounding group sues FDA for removing Lilly’s obesity drug from its shortages list
STAT Plus: Pharmalittle: We’re reading about an activist investor stake in Pfizer, Trump backing off drug-pricing plan, and more
The biotech news stories you need to read this morning
All Coverage
advertisement
